GV20 Therapeutics
GV20 Therapeutics is a biotech company in Newton, United States, founded in 2016. It has raised $1.5M across 2 rounds, most recently a Series B in October 2021.
- Headquarters
- Newton, Massachusetts
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- gv20tx.com
- Total Funding
- $1.5M
- Last Round
- Series BOct 2021
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
GV20 Therapeutics is a clinical-stage, AI-powered biotherapeutics company developing next-generation cancer treatments. Its proprietary STEAD platform integrates massive B-cell repertoire data, -omics data, and advanced AI models to uncover novel tumor targets and antibodies that elude other approaches. The pipeline includes best-in-class and first-in-class monoclonal and bispecific antibodies plus antibody-drug conjugates, led by GV20-0251 — a fully human antibody targeting the novel immune checkpoint IGSF8 — which advanced from target discovery to an IND in three years and is now in Phase 1/2a trials.
Summary
It lists 11–50 employees. It has raised $1.5M in total across 2 rounds, most recently a Series B round in Oct 2021. Investors include Coatue Management, IDG Capital and 3W Investment.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2021
Sign up to see all 2 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gv20-therapeutics"><img src="https://indexed.vc/api/badge/company/gv20-therapeutics" alt="GV20 Therapeutics on Indexed.vc" width="260" height="76" /></a>